Gurugram-based startup Lifesigns, a pioneer in intelligent patient monitoring solutions, has secured funding from Healthcare Capital, the investment arm of the Kauvery Hospital Group.
The investment will primarily advance Lifesigns’ artificial intelligence (AI) and predictive algorithm capabilities, further enhancing its proprietary patient monitoring platform. Lifesigns remains the only solution offering USFDA-approved hardware, software, dashboard, and AI integration, delivering proactive alerts and predictive insights across the patient journey—from ambulances to hospitals and home care.
While Lifesigns continues to focus on AI advancements, the company is also gearing up for its next funding round in the next couple of months, where it plans to unveil new tech product and market expansion initiatives. With this strategic investment, Lifesigns is set to accelerate innovation, solidify its position as a leader in health tech, and contribute to shaping the future of patient monitoring.
Healthcare Capital, backed by over 25 years of expertise in the healthcare sector, brings deep industry knowledge and a commitment to enhancing patient care through cutting-edge technology. By investing in Lifesigns, Healthcare Capital reinforces its vision of integrating best-in-class innovations to improve patient outcomes and streamline healthcare workflows.
